A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
Titel:
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
Auteur:
Ravandi, Farhad Gojo, Ivana Patnaik, Mrinal M. Minden, Mark D. Kantarjian, Hagop Johnson-Levonas, Amy O. Fancourt, Craig Lam, Raymond Jones, Mary Beth Knox, Clayton D. Rose, Shelonitda Patel, Payal Shah Tibes, Raoul